LISATA THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $124.00K, a 1450.00% increase year-over-year.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $8.00K.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $155.00K, a 99.41% decline from fiscal 2022.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $26.10M, a 108641.67% increase from fiscal 2021.
- LISATA THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $24.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $124.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $124.00K 10-Q · filed 2026-05-11 | $124.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-11 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $155.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $155.00K 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $26.10M 10-K · filed 2023-03-30 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $24.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-05 | |
| 2019-06-30 | $37.00K 10-Q · filed 2019-08-08 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $355.00K 10-K · filed 2020-03-05 |
| 2018-09-30 | $13.00K 10-Q · filed 2019-11-06 | $355.42K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $302.00K 10-Q · filed 2019-08-08 | $342.42K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $40.00K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $424.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $14.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2011-12-31 | $7.10K 10-K · filed 2013-03-11 | |
| 2010-12-31 | $140.10K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |